Ipilimumab Receives FDA Priority Review Designation
- Details
- Category: Bristol-Myers Squibb

Lilly Halts Development of Semagacestat for Alzheimer's Disease
- Details
- Category: Eli Lilly and Company

Lundbeck reports strongly increasing profits with EBIT growth of 30%
- Details
- Category: Lundbeck

Abbott Launches New Psoriasisanswers.com Web site
- Details
- Category: Abbott

Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial
- Details
- Category: Amgen

Pfizer Reports Second-Quarter 2010 Results
- Details
- Category: Pfizer

Image of new antibiotic in action opens up new opportunities
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- TEMPO study further demonstrates the benefits of Azilect® in early Parkinson's disease patients
- Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
- Shire Proposes to Expand Specialist Gastrointestinal Portfolio
- AstraZeneca Second Quarter and Half Year Results 2010
- Bayer increases sales and earnings in the second quarter
- FDA Grants Priority Review to Cladribine Tablets
- Lilly Reports Strong Second-Quarter 2010 Results